NME6 and colorectal carcinoma: Low expression levels of five purine metabolism‐related genes—ADSL, APRT, ADCY3, NME3, and NME6—were associated with worse prognosis in CRC patient subgroups, including wild‐type TP53, mutant TP53, and microsatellite‐stable phenotypes.